After decades of regulatory review, Americans may soon see a new sunscreen ingredient on store shelves.
The U.S. Food and Drug Administration on June 9 approved bemotrizinol — also known as BEMT or PARSOL Shield — as an over-the-counter sunscreen active ingredient, marking the first addition to the federal sunscreen monograph since the late 1990s.
Dermatologists and sunscreen researchers say the ingredient could strengthen protection against ultraviolet radiation — particularly UVA rays — which are linked to skin aging and melanoma risk. The decision comes as skin cancer remains the most common cancer in the U.S. According to the Skin Cancer Foundation, 1 in 5 Americans will develop skin cancer by age 70.
“This ingredient fills what has been a very large gap, and it does so with a significant body of safety data showing lack of health concerns and lack of health harm,” said David Andrews, a chemist and the Chief Science Officer at the Environmental Working Group who focuses on studying sunscreen. “With that safety substantiation in the benefit it provides, I'm excited for this as a potential option for sunscreen formulators.”
The FDA approval comes seven months after issuing the proposed order and more than two decades after the ingredient entered the regulatory review process. Bemotrizinol has been used in sunscreens in Europe and other countries since 1999.
‘We’ve all been hoping for this’
Bemotrizinol is a synthetically manufactured sunscreen filter that differs from many existing sunscreen ingredients because of its large molecular size. According to Andrews, the ingredient is not readily absorbed through the skin, which contributed to a substantial body of safety data supporting its approval.
Read More
Outside of zinc oxide and titanium dioxide, bemotrizinol is the first non-mineral sunscreen ingredient to receive a full FDA determination as generally recognized as safe and effective under the agency’s current standards.
For dermatologists, the approval addresses a long-standing limitation in the U.S. sunscreen market.
“It’s really exciting, because we’ve all been hoping for this for years,” said Kristen Whitney, a dermatologist at Allegheny Health Network. “With the more research that we’re getting with the sun and the effects that it can do, and the need for really good, solid protection, that’s been the gap in our sunscreens with the full UVA protection.”
Filling a gap in UVA protection
Sunlight contains two primary types of ultraviolet radiation that reach the Earth’s surface: ultraviolet A, or UVA, and ultraviolet B, or UVB.
Whitney explained that UVB rays are largely responsible for sunburns, while UVA rays penetrate deeper into the skin and are associated with premature aging, wrinkles and an increased risk of skin cancer. Both types of radiation can damage skin cells and contribute to cancer development.
Unlike UVB radiation, which is strongest during the summer months, UVA exposure remains relatively constant throughout the year.
For Andrews, one of bemotrizinol’s strongest advantages is its ability to filter UVA radiation.
“UVA rays can contribute to wrinkled skin, aging and increased rates of skin cancer, in particular in association with increased melanoma risk,” he said. “For that reason, we’ve been organizationally highlighting the importance of UVA protection in sunscreen.”
The approval, Andrews said, could improve the performance of many sunscreen products, because bemotrizinol can be combined with other FDA-approved sunscreen ingredients.
“This new ingredient goes a long way to potentially shifting a lot of the market towards stronger UVA protection in sunscreens in the U.S, in part because its approval allows it to be used in combination with any of the other approved ingredients in the U.S., so that stronger UVA protection could actually be used to boost most formulations on the marketplace,” he said.
Historically, sunscreen products in the United States have relied on either mineral or chemical active ingredients.
Whitney said mineral sunscreens use zinc oxide or titanium dioxide to protect the skin from ultraviolet radiation, while chemical sunscreens use ingredients that absorb UV energy before it can damage skin cells.
In addition to protecting from UVA rays, bemotrizinol may offer an alternative that makes it easier for consumers to wear.
“The problem with titanium and zinc-based sunscreens is that a lot of people don't like the feel or the look of them,” Whitney said. “They can be heavy and leave a white cast. The bemotrizinol is going to blend in much more easily and efficiently, and be more elegant, so to speak.”
Choosing a sunscreen
According to Whitney, the best sunscreen to purchase is the one that you'll use regularly. When picking sunscreen from the shelves, however, there are some important ingredients and guidelines to consider.
When shopping for sunscreen, Whitney recommends choosing products labeled broad spectrum with a sun protection factor, or SPF, of at least 30. People who spend significant time outdoors, swim or sweat heavily should also look for water-resistant formulas.
“That SPF number specifically tells you how effective that sunscreen is for blocking UVB rays, or the burning rays,” Whitney said. “SPF 30 is going to block about 97% of UVB rays. SPF 50 bumps that up to about 98%, but no sunscreen is going to block 100%.”
Whitney called bemotrizinol the best of both worlds.
“[Bemotrizinol] has a really great safety profile,” she said. “It doesn’t get absorbed, it’s very easy to apply and has that elegant, sheer finish that people like.”
Although the FDA has finalized approval, consumers are unlikely to see bemotrizinol-containing sunscreens immediately.
Andrews estimated that products containing the ingredient may not become available until late 2026 or early 2027.
For the first 18 months, Netherlands-based dsm-firmenich will have market exclusivity for bemotrizinol in the United States. Still, experts say the approval represents a significant step forward for sunscreen.
“I can't wait for it to hit the shelves and for us to have another safe, effective option out there,” said Whitney.
Ava Dzurenda (ava.dzurenda@gmail.com) is a science writer and exercise physiologist based in White Oak.




Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.